Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Santarus and VeroScience Announce Publication of AACE Expert Panel Recommendations for Cycloset (bromocriptine mesylate) for the Management of Type 2 Diabetes
Santarus and VeroScience Announce Publication of AACE Expert Panel Recommendations for Cycloset (bromocriptine mesylate) for the Management of Type 2 Diabetes
Santarus and VeroScience Announce Publication of AACE Expert Panel Recommendations for Cycloset (bromocriptine mesylate) for the Management of Type 2 Diabetes
Submitted by
admin
on March 6, 2013 - 9:44am
Source:
Yahoo/BusinessWire
News Tags:
Santarus
type 2 diabetes
Cycloset
VeroScience
Headline:
Santarus and VeroScience Announce Publication of AACE Expert Panel Recommendations for Cycloset (bromocriptine mesylate) for the Management of Type 2 Diabetes
Do Not Allow Advertisers to Use My Personal information
